T 0739/10 (RNase H gapmers/ISIS) of 22.09.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:T073910.20110922
- Date of decision
- 22 September 2011
- Case number
- T 0739/10
- Petition for review of
- -
- Application number
- 93902851.0
- IPC class
- C07H 21/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antisense oligonucleotides
- Applicant name
- Isis Pharmaceuticals, Inc.
- Opponent name
- Vernalis (R & D) Limited
Santaris Pharma A/S - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- -
- Keywords
- Adaptation of the description after a decision to maintain the patent in amended form - consistent with the amended set of claims (yes)
- Catchword
- -
- Cited cases
- T 0506/04
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is maintained on the basis of the claims filed on 3 November 2006 and allowed by the then competent board of appeal in the decision T 506/04 (supra) and the description adapted thereto filed as main request on 15 July 2011.